Sep 30, 2024, 15:56
Elad Sharon: New framework to consider phase 1 clinical trials
Elad Sharon, Medical Oncologist at Dana-Farber, shared on X:
“Nagla Abdel Karim gives us a new framework to consider phase 1 clinical trials
Inova Health’s Evolving Therapies meeting!”
Source: Elad Sharon/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 24, 2024, 17:39
Dec 24, 2024, 17:10
Dec 24, 2024, 16:42
Dec 24, 2024, 16:39
Dec 24, 2024, 16:17